Skip Navigation

VAERS Bibliography - December 2000

  1. Health professionals are unsure about second measles, mumps, and rubella vaccination.  BMJ 2001 Jan 13;322(7278):E

  2. Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students).  Pediatrics 2000 Dec;106(6):1500-4

  3. Artimos de Oliveira S, Jin L, Siqueira MM, Cohen BJ. Atypical measles in a patient twice vaccinated against measles: transmission from an unvaccinated household contact.  Vaccine 2000 Dec 8;19(9-10):1093-6

  4. Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection.  J Immunol 2001 Jan 1;166(1):226-31

  5. Arya S, Chellani H, Pandey J. Evaluation of Safety of Oral Vitamin A Megadose Co-Administered with Measles Vaccination.  Indian Pediatr 2000 Dec 7;37(12):1341-7

  6. Bell BP. Hepatitis A vaccine.  Pediatr Infect Dis J 2000 Dec;19(12):1187-8

  7. Beran J, De Clercq N, Dieussaert I, Van Hoecke C. Reactogenicity and Immunogenicity of a Lyme Disease Vaccine in Children 2-5 Years Old.  Clin Infect Dis 2000 Dec;31(6):1504-7

  8. Beyer WE. Routine influenza vaccination for healthy children-old concept, new technologies.  Arch Dis Child 2000 Dec;83(6):461-2

  9. Borrow R, Joseph H, Andrews N, Acuna M, Longworth E, Martin S, Peake N, Rahim R, Richmond P, Kaczmarski E, et al. Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.  Vaccine 2000 Dec 8;19(9-10):1129-32

  10. Chaisson RE. New developments in the treatment of latent tuberculosis.  Int J Tuberc Lung Dis 2000 Dec;4(12 Suppl 2):S176-81

  11. Christenson B, Hellstrom U, Sylvan SP, Henriksson L, Granstrom M. Impact of a vaccination campaign on adult immunity to diphtheria.  Vaccine 2000 Dec 8;19(9-10):1133-40

  12. Conyn-Van Spaendonck MA M, de Melker HE H, Abbink F, Elzinga-Gholizadea N, Kimman TG, van Loon T T. Immunity to Poliomyelitis in the Netherlands.  Am J Epidemiol 2001 Feb 1;153(3):207-14

  13. Couch RB. Influenza: Prospects for Control.  Ann Intern Med 2000 Dec 19;133(12):992-8

  14. Cuthbert JA. Hepatitis A: Old and New.  Clin Microbiol Rev 2001 Jan;14(1):38-58

  15. Danovaro-Holliday MC, LeBaron CW, Allensworth C, Raymond R, Borden TG, Murray AB, Icenogle JP, Reef SE. A large rubella outbreak with spread from the workplace to the community.  JAMA 2000 Dec 6;284(21):2733-9

  16. de Kleijn ED, de Groot R, Lafeber AB, Labadie J, van Limpt KC, Visser J, Berbers GA, van Alphen L, Rumke HC. Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations.  Vaccine 2000 Dec 8;19(9-10):1141-8

  17. De Wals P. Does informing patients of the risk of acquiring Guillain-Barre syndrome following influenza vaccination have an effect on their willingness to be vaccinated?  Can Commun Dis Rep 2000 Dec 1;26(23):205-7

  18. Edmunds W, Dejene A, Mekonnen Y, Haile M, Alemnu W, Nokes D. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa.  Health Policy Plan 2000 Dec;15(4):408-16

  19. Ehresmann KR, Mills WA, Loewenson PR, Moore KA. Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implications for public health and provider education.  Am J Public Health 2000 Dec;90(12):1917-20

  20. Eicken C, Sharma V, Klabunde T, Owens RT, Pikas DS, Hook M, Sacchettini JC. Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi.  J Biol Chem 2001 Jan 3;

  21. Erramouspe J, Heyneman CA. treatment and prevention of otitis media.  Ann Pharmacother 2000 Dec;34(12):1452-68

  22. Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization.  JAMA 2000 Dec 27;284(24):3145-50

  23. Fischman J. Vaccinating against paralysis.  US News World Rep 2000 Dec 25;129(25):66-7

  24. Franzen D. Clinical Efficacy of Pneumococcal Vaccination - A Prospective Study in Patients with Longstanding Emphysema and / or Bronchitis.  Eur J Med Res 2000 Dec 29;5(12):537-40

  25. Friedman MS, Blake PA, Koehler JE, Hutwagner LC, Toomey KE. Factors influencing a communitywide campaign to administer hepatitis A vaccine to men who have sex with men.  Am J Public Health 2000 Dec;90(12):1942-6

  26. Gdalevich M, Ephros M, Mimouni D, Grotto I, Shpilberg O, Eldad A, Ashkenazi I. Measles epidemic in israel-successful containment in the military.  Prev Med 2000 Dec;31(6):649-51

  27. Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine.  Arch Dis Child 2000 Dec;83(6):488-91

  28. Haller AA, Miller T, Mitiku M, Coelingh K. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector.  J Virol 2000 Dec;74(24):11626-35

  29. Harel Z, Ipp L, Riggs S, Vaz R, Flanagan P. Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox.  J Adolesc Health 2001 Jan;28(1):26-9

  30. Kuehnert MJ, Cardo DM. Infections Associated with Health-care Personnel: Vaccine-preventable Diseases and Bloodborne Pathogens.  Curr Infect Dis Rep 2000 Dec;2(6):475-83

  31. Macedo G, Maia JC, Gomes A, Teixeira A, Ribeiro T. Efficacy of a reinforced protocol of HBV vaccination in cirrhotic patients waiting for orthotopic liver transplantation.  Transplant Proc 2000 Dec;32(8):2641

  32. MacLennan J, Obaro S, Deeks J, Lake D, Elie C, Carlone G, Moxon ER, Greenwood B. Immunologic Memory 5 Years after Meningococcal A/C Conjugate Vaccination in Infancy.  J Infect Dis 2001 Jan;183(1):97-104

  33. Mallet E, Fabre P, Pines E, Salomon H, Staub T, Schodel F, Mendelman P, Hessel L, Chryssomalis G, Vidor E, et al. Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants. Hexavalent Vaccine Trial Study Group.  Pediatr Infect Dis J 2000 Dec;19(12):1119-27

  34. Mandl S, Hix L, Andino R. Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors.  J Virol 2001 Jan;75(2):622-7

  35. Martin J, Ferguson GL, Wood DJ, Minor PD. The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in poland.  Virology 2000 Dec 5;278(1):42-9

  36. Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, Salvaneschi L, Rondini G, Avanzini MA, Cuccia M. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.  Clin Immunol 2000 Dec;97(3):234-40

  37. Milne LM. Difficulties in assessing the relationship, if any, between mumps vaccination and diabetes mellitus in childhood.  Vaccine 2000 Dec 8;19(9-10):1018-25

  38. Montalto NJ, Gum KD, Ashley JV. Updated treatment for influenza A and B.  Am Fam Physician 2000 Dec 1;62(11):2467-76

  39. Morris DL, Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ. Measles vaccination and inflammatory bowel disease: a national British Cohort Study.  Am J Gastroenterol 2000 Dec;95(12):3507-12

  40. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction.  Circulation (Online) 2000 Dec 19;102(25):3039-45

  41. Nielsen C. Coping with vaccine manufacturing delays.  Cleve Clin J Med 2000 Dec;67(12):898-900, 902

  42. Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, Kaufman SF, Lewis JE, Vugia DJ, Powell KE, et al. Trends in intussusception-associated hospitalizations and deaths among US infants.  Pediatrics 2000 Dec;106(6):1413-21

  43. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up.  Pediatr Infect Dis J 2000 Dec;19(12):1127-34

  44. Patja A, Makinen-Kiljunen S, Davidkin I, Paunio M, Peltola H. Allergic Reactions to Measles-Mumps-Rubella Vaccination.  Pediatrics 2001 Feb;107(2):E27

  45. Petrovic M, Roberts R, Ramsay M. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.  BMJ 2001 Jan 13;322(7278):82-5

  46. Rimmelzwaan GF, Nieuwkoop N, Brandenburg A, Sutter G, Beyer WE, Maher D, Bates J, Osterhaus AD. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.  Vaccine 2000 Dec 8;19(9-10):1180-7

  47. Shouval D. Is universal vaccination against hepatitis B sufficient for control of HBV infection? Lessons from the immunization campaign in Italy.  J Hepatol 2000 Dec;33(6):1009-11

  48. Sleeman K, Knox K, George R, Miller E, Waight P, Griffiths D, Efstratiou A, Broughton K, Mayon-White RT, Moxon ER, et al. Invasive Pneumococcal Disease in England and Wales: Vaccination Implications.  J Infect Dis 2001 Jan;183(2):239-46

  49. Stokley S, Rodewald LE, Maes EF. The impact of record scattering on the measurement of immunization coverage.  Pediatrics 2001 Jan;107(1):91-6

  50. Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, Santonastasi F, Marzolini A, Ciccozzi M, Moiraghi A. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy.  J Hepatol 2000 Dec;33(6):980-5

  51. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Maki M, Suzuki H, Ojika K, Ueda R. Hepatitis B virus infection among residents of a nursing home for the elderly: seroepidemiological study and molecular evolutionary analysis.  J Med Virol 2000 Dec;62(4):456-62

  52. Trevejo RT. Rabies preexposure vaccination among veterinarians and at-risk staff.  J Am Vet Med Assoc 2000 Dec 1;217(11):1647-50

  53. van Den Hof S, de Melker HE, Berbers GA, van Der Kraak PH, Spaendonck MA. Antibodies to Haemophilus influenzae Serotype b in The Netherlands a Few Years after the Introduction of Routine Vaccination.  Clin Infect Dis 2001 Jan;32(1):2-8

  54. Van Herck K, Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence.  J Med Virol 2001 Jan;63(1):1-7

  55. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview.  Vaccine 2000 Dec 8;19(9-10):1026-37

  56. Weaver M, Krieger J, Castorina J, Walls M, Ciske S. Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines.  Arch Intern Med 2001 Jan 8;161(1):111-20

  57. Weingart CL, Keitel WA, Edwards KM, Weiss AA. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.  Infect Immun 2000 Dec;68(12):7175-9

  58. Wiedermann U, Kundi M, Vollmann U, Kollaritsch H, Ebner C, Wiedermann G. Different HBs Antibody versus Lymphoproliferative Responses after Application of a Monovalent (Hepatitis B) or Combined (Hepatitis A + Hepatitis B) Vaccine.  Int Arch Allergy Immunol 2000 Dec;123(4):349-53

[top]